AGM/EGMApr 29, 2026, 11:32 AM
HCWB to Vote on 1:5 to 1:20 Reverse Stock Split to Maintain Nasdaq Listing
AI Summary
HCW Biologics Inc. will hold its 2026 Annual Meeting of Stockholders on June 15, 2026, to vote on several key proposals. These include a reverse stock split ranging from 1:5 to 1:20 to maintain Nasdaq listing, approval for the issuance of 2,477,292 common stock purchase warrants, and the repricing of 3,020,410 existing warrants from $2.41 to $0.6055 per share. The Board recommends voting FOR all proposals, noting the reverse split is crucial for listing and warrant approvals are recurring obligations. Additionally, stockholders will elect directors and ratify the auditor.
Key Highlights
- Proposal for a reverse stock split (1:5 to 1:20) to maintain Nasdaq listing.
- Approval for issuance of up to 2,477,292 common stock purchase warrants.
- Approval for repricing 3,020,410 existing warrants from $2.41 to $0.6055 per share.
- 2026 Annual Meeting of Stockholders scheduled for June 15, 2026, virtually.
- Record date for voting set as April 22, 2026.
- Bylaw amendment lowers quorum requirement to 33 1/3% of voting power.
- Election of two Class II directors.
- Ratification of Crowe LLP as independent auditor for 2026.